Literature DB >> 36205014

Do conclusions drawn from spot urine sodium measurements agree with the conclusions drawn from the 24-h urine measurements?

Theodore W Kurtz1, Michal Pravenec2, Stephen E DiCarlo3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36205014      PMCID： PMC9555751          DOI： 10.1097/HJH.0000000000003254

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.776


× No keyword cloud information.
  6 in total

1.  Reducing the population's sodium intake: the UK Food Standards Agency's salt reduction programme.

Authors:  Laura A Wyness; Judith L Butriss; Sara A Stanner
Journal:  Public Health Nutr       Date:  2011-06-23       Impact factor: 4.022

2.  Contribution of reformulation, product renewal, and changes in consumer behavior to the reduction of salt intakes in the UK population between 2008/2009 and 2016/2017.

Authors:  Mathilde Gressier; Franco Sassi; Gary Frost
Journal:  Am J Clin Nutr       Date:  2021-05-08       Impact factor: 7.045

3.  Spot urinary sodium to monitor relative changes in population salt intake during the UK salt reduction programme.

Authors:  Monique Tan; Changqiong Wang; Jing Song; Feng J He; Graham A MacGregor
Journal:  J Hypertens       Date:  2022-07-01       Impact factor: 4.776

4.  Mechanism-based strategies to prevent salt sensitivity and salt-induced hypertension.

Authors:  Theodore W Kurtz; Michal Pravenec; Stephen E DiCarlo
Journal:  Clin Sci (Lond)       Date:  2022-04-29       Impact factor: 6.876

Review 5.  A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.

Authors:  F J He; G A MacGregor
Journal:  J Hum Hypertens       Date:  2008-12-25       Impact factor: 3.012

6.  Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study.

Authors:  Christopher Millett; Anthony A Laverty; Neophytos Stylianou; Kirsten Bibbins-Domingo; Utz J Pape
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.